Alpine Global Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-111,132	Closed	-$2.04M	–	132
2024 Q4	$2.04M	Buy	+111,132	New	+$2.04M	0.27%	64